Related search

Characterizing Cellular Responses During Oncolytic Maraba Virus Infection

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

A Clinical Study of a Cell-Based MAGE-A3 Active Immunotherapy in Advanced Melanoma Patients

Journal of Cancer
Oncology
2011English

Booster Vaccination of Cancer Patients With MAGE-A3 Protein Reveals Long-Term Immunological Memory or Tolerance Depending on Priming

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Monoclonal Anti-Mage-3 CTL Responses in Melanoma Patients Displaying Tumor Regression After Vaccination With a Recombinant Canarypox Virus

Journal of Immunology
AllergyImmunology
2003English

Distinct Human Immunodeficiency Virus Type 1 Subtype a Virus Circulating in West Africa: Sub-Subtype A3

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2004English

Construction, Characterization and Preclinical Evaluation of MTBVAC, the First Live-Attenuated M. Tuberculosis-Based Vaccine to Enter Clinical Trials

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2013English

P3.01-83 Use of Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus in Preclinical Models of NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Oncolytic Maraba Virus Armed With Tumor Antigen Boosts Vaccine Priming and Reveals Diverse Therapeutic Response Patterns When Combined With Checkpoint Blockade in Ovarian Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Oncolytic Potency and Reduced Virus Tumor-Specificity in Oncolytic Virotherapy. A Mathematical Modelling Approach

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy